PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 75 filers reported holding PASSAGE BIO INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,263,528 | -30.1% | 4,959,769 | 0.0% | 1.74% | -68.7% |
| Q2 2023 | $4,668,631 | -1.7% | 4,959,769 | 0.0% | 5.54% | -44.1% |
| Q1 2023 | $4,749,971 | -30.6% | 4,959,769 | 0.0% | 9.90% | -30.1% |
| Q4 2022 | $6,844,481 | +10.4% | 4,959,769 | 0.0% | 14.16% | +34.0% |
| Q3 2022 | $6,200,000 | -47.0% | 4,959,769 | 0.0% | 10.57% | -41.1% |
| Q2 2022 | $11,705,000 | -23.9% | 4,959,769 | 0.0% | 17.94% | +16.9% |
| Q1 2022 | $15,375,000 | -51.2% | 4,959,769 | 0.0% | 15.35% | -8.9% |
| Q4 2021 | $31,495,000 | -36.2% | 4,959,769 | 0.0% | 16.84% | -17.6% |
| Q3 2021 | $49,399,000 | -24.8% | 4,959,769 | 0.0% | 20.45% | -6.0% |
| Q2 2021 | $65,667,000 | -24.3% | 4,959,769 | 0.0% | 21.76% | +28.8% |
| Q1 2021 | $86,697,000 | – | 4,959,769 | – | 16.89% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,959,769 | $4,668,631 | 5.54% |
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $2,348,047 | 2.02% |
| BML Capital Management, LLC | 2,058,767 | $1,937,917 | 1.74% |
| Lynx1 Capital Management LP | 1,167,343 | $1,098,820 | 0.72% |
| Acuitas Investments, LLC | 418,173 | $393,626 | 0.23% |
| Orbimed Advisors | 10,124,576 | $9,530,263 | 0.17% |
| Frazier Life Sciences Management, L.P. | 1,850,000 | $1,741,405 | 0.10% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $282,390 | 0.04% |
| Marquette Asset Management, LLC | 86,050 | $80,999 | 0.02% |
| Annandale Capital, LLC | 54,338 | $51 | 0.02% |